204 results
Page 3 of 11
6-K
EX-99.1
hsyxet
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.1
zfvyn1bl7e56 x17
18 Nov 21
Notice of Annual General and Special Meeting of Shareholders
10:36am
6-K
EX-99.2
vplool0d5wclpq4 42
16 Nov 21
RepliCel’s Clinical Advisory Team Delivers Skin Rejuvenation Clinical Study Synopsis to its Japanese Regulatory and Clinical Study Management Team
4:03pm
6-K
EX-99.1
stutffbb9nbzjjznki
16 Nov 21
RepliCel’s Clinical Advisory Team Delivers Skin Rejuvenation Clinical Study Synopsis to its Japanese Regulatory and Clinical Study Management Team
4:03pm
6-K
EX-99.1
rjf5x
2 Nov 21
RepliCel Announces Dermal Injector Update
12:31pm
6-K
EX-99.2
qzarpe n9wtbqus
2 Nov 21
RepliCel Announces Dermal Injector Update
12:31pm
6-K
EX-99.1
ki1jyxt6z u1rqhv
21 Oct 21
Current report (foreign)
3:49pm
6-K
EX-99.1
v811z1m7
18 Aug 21
RepliCel Life Sciences Announces Closing of Debt Settlement
12:34pm
6-K
EX-99.2
i5xpatk1zj 19
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.1
gvajwrb
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.5
3krnrcvyhdvfpe
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.7
v9puaic9
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.3
rq1c1g
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am
6-K
EX-99.2
xsb9ea6mzl jq
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am
6-K
EX-99.3
e4dwdnu1tiy8z
13 Aug 21
RepliCel Life Sciences Announces Debt Settlement
12:00am
6-K
EX-99.1
9a4hs3 o1
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am
6-K
EX-99.1
orai9cg 1kajb
13 Aug 21
RepliCel Life Sciences Announces Debt Settlement
12:00am
6-K
EX-99.2
z7sw9p
13 Aug 21
51-102F3 Material Change Report
12:00am